Fig. 1

Schedule of baseline, follow-up, and final visits for enrolled patients. *Site staff virtual 2-week visit. ^†Should the study sponsor extend the study an additional year, total per-patient follow-up will extend to 24 months. Additional in-person visits for OAB will occur for patients to receive their prescription refills 2 to 4 times in year 2 and to check for AEs around weeks 78 and 104. ^‡Site staff virtual follow-up to record any new safety events. AE, adverse event; OAB, overactive bladder